About Baby Genes
Baby Genes is a company based in Golden (United States) founded in 2013 was acquired by ArcherDX in January 2019. Baby Genes operates in a competitive market with competitors including ArcherDX, Natera, Variantyx, ImaginAb and RareCyte, among others.
- Headquarter Golden, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Baby Genes
Detailed funding history for Baby Genes
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Baby Genes
Baby Genes has secured backing from 1 investor. Prominent investors backing the company include ArcherDX.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Molecular cancer diagnostic products are developed using patented AMP technology.
|
Locked | Locked | Locked |
Investor details for Baby Genes
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Baby Genes
Investment portfolio details for Baby Genes
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Baby Genes
Detailed financials for Baby Genes
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Baby Genes Comparisons
Peer comparison for Baby Genes
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Baby Genes
Baby Genes operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ArcherDX, Natera, Variantyx, ImaginAb and RareCyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Genomics data analysis platform for healthcare diagnostics is offered.
|
|
| Locked | Locked | Locked |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
|
|
| Locked | Locked | Locked |
Developer of technologies for the analysis of rare and single cells in the blood
|
|
| Locked | Locked | Locked |
Genetic sequencing is provided for late-stage cancer patients.
|
Detailed competitors of Baby Genes
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Baby Genes
Complete news archive for Baby Genes
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Baby Genes
Baby Genes was founded in 2013.
Baby Genes is headquartered in Golden, United States. It is registered at Golden, Colorado, United States.
Baby Genes was founded in 2013 and is based in Golden, United States. Genomic diagnostic solutions for neonates are offered within the healthcare sector, focusing on whole-exome sequencing through the flagship BG Newborn Panel to detect pathogenic variants linked to congenital disorders. Carrier testing services are also provided to support genetic screening efforts.
Baby Genes's top competitors include Natera, ImaginAb and Lantern Pharma.
Baby Genes has 1 investor. Key investors include ArcherDX.